glp 1 shortage fda GLP-1 No Longer on FDA's Drug List FDA issued 25 warning letters

Therapeutic (relatively low) doses of psychostimulants, such as methylphenidate and amphetamine, improve performance on working memory tasks both in normal subjects and those with ADHD

Lyophilized peptide powders require bacteriostatic water reconstitution and sterile technique

doi: 10.1080/09513590.2022.2089106

Byetta may cause new or worse problems with kidney function, including kidney failure

On GLP-1 medications, appetite often drops before your protein needs do, and protein is usually the hardest nutrient to catch up on later

That may increase the chance of side effects or make it harder for your provider to understand your response